News
Novartis has shared positive results from a phase 3b study of Fabhalta (iptacopan) in a new population of patients with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback